Roggwil, Switzerland (PRWEB) December 20, 2012
Echinacea is a popular herb used to treat colds and flu in many parts of the world, yet reports on its efficacy have been mixed. With the recent discovery of anti-viral, anti-inflammatory and immune modulating activity, there has been renewed interest in clinical research on Echinacea. According to Roland Schoop, Medical Researcher for Bioforce AG, Switzerland “Despite decades of pharmaceutical research, scientists have not found a specific way to prevent colds or flu. The key reason for this is the enormous variety of viruses causing colds or flu – today, more than 200 different respiratory viruses are known and new viruses are discovered every year. An alternative approach to preventing colds is to build the body’s immune resistance. That is why we have focused so much research on the effect Echinaforce has on the immune system.”
On September 27, 2012 Prof. Stephan Pleschka, Institute for Medical Virology, University Glessen, Germany, Dr. Margaret Ritchie, University of London, Prof. Ronald Eccles, Director of Common Cold Centre, University Cardiff (UK), Dr. Andreas Schapowal, ENT specialist (CH), and Prof. Michael Heinrich, School of Pharmacy, University College, London (UK) gathered in London to discuss the latest research on a Swiss Echinacea extract Echinaforce®. Their comments on the efficacy of Echinaforce® have been are available on You Tube http://www.youtube.com/user/officialechinaforce?feature=watch. The report on this conference is also available by calling 800-641-7555.
Bioforce AG, Rogwill, Switzerland is known for its “gold standard” research on herbs. Bioforce received the American Botanical Council’s Varro E. Tyler Commercial Investment in Phytomedicinal Research Award in 2011. It’s meta-analysis on Echinacea was chosen as one of the top 25 research papers of 2006 by the prestigious Annual Bibliography of Significant Advances in Dietary Supplement Research, published by The National Institutes of Health, (NIH) Office of Dietary Supplements.
Bioforce USA has created long-term strategic alliances with European manufacturers of product lines that have years of clinical research support for safety and efficacy, plus years of repeat consumer use. Bioforce USA has brought these lines, which include A. Vogel, Sanhelios, Herbatint, Bionorica, Annemarie Börlind and SECURE Denture Adhesives exclusively to the United States for distribution through natural products and health food stores.
For more information call Eileen Sheets at 800-641-7555 x100 or esheets(at)bioforceusa(dot)com
Read the full story at http://www.prweb.com/releases/2012/12/prweb10252805.htm.
Copyright©2012 Vocus, Inc.
All rights reserved